Compare IOSP & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IOSP | PAHC |
|---|---|---|
| Founded | 1938 | 1946 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.7B |
| IPO Year | 1998 | 2014 |
| Metric | IOSP | PAHC |
|---|---|---|
| Price | $77.08 | $52.82 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 3 |
| Target Price | ★ $124.00 | $34.33 |
| AVG Volume (30 Days) | 184.4K | ★ 298.4K |
| Earning Date | 05-21-2026 | 01-01-0001 |
| Dividend Yield | ★ 2.28% | 0.92% |
| EPS Growth | 228.87 | ★ 1883.33 |
| EPS | ★ 4.67 | 1.32 |
| Revenue | ★ $1,778,000,000.00 | $833,350,000.00 |
| Revenue This Year | $7.48 | $17.03 |
| Revenue Next Year | $5.13 | $3.82 |
| P/E Ratio | ★ $16.32 | $39.80 |
| Revenue Growth | N/A | ★ 4.12 |
| 52 Week Low | $70.10 | $16.16 |
| 52 Week High | $102.26 | $56.30 |
| Indicator | IOSP | PAHC |
|---|---|---|
| Relative Strength Index (RSI) | 36.18 | 60.45 |
| Support Level | $74.76 | $37.09 |
| Resistance Level | $80.82 | $56.30 |
| Average True Range (ATR) | 2.74 | 1.99 |
| MACD | -0.98 | -0.28 |
| Stochastic Oscillator | 17.46 | 41.36 |
Innospec Inc manufactures and sells a variety of chemicals and fuel additives. The firm organizes itself into three segments based on product type. The Performance Chemicals segment that derives maximum revenue, provides technology-based solutions for its customers' processes or products in personal care, home care, agrochemical, construction, mining and other industrial markets. The Fuel Specialties segment develops, manufactures, blends, markets and supplies a range of specialty chemical products used as additives in diesel, jet, marine, fuel oil and other fuels. The Oilfield Services segment develops and markets chemical solutions for drilling, completion, production, DRA and oil and gas applications.
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.